Clin2
NCT07445581Possibly a fitNot yet recruiting

Tanhuo Decoction for seniors with heart and brain artery issues

Acute Coronary Syndrome Comorbid With Cerebral Atherosclerosis

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests a traditional Chinese herbal formula, Tanhuo Decoction, for elderly patients who recently had a heart attack (acute coronary syndrome) and also have brain artery narrowing or a history of stroke. It aims to see if the medicine helps improve recovery and reduce future risks.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
480 people
Ages
60 years and older
Study type
Interventional

Who can take part

  • You are 60 years or older
  • You recently had a heart attack and your blood pressure and heart rate have been stable for at least 24 hours
  • You have been diagnosed with narrowing of arteries in your brain or neck (at least 50% blockage), or have had a prior stroke or mini-stroke
  • You have symptoms of "fire-heat syndrome" as assessed by your doctor, such as a red tongue, yellow coating, constipation, fever, or feeling irritable

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07041359Recruiting· Phase 4
Traditional Chinese medicine for elderly heart disease patients with ongoing symptoms

This trial tests whether traditional Chinese medicine can help elderly patients with coronary heart disease who still have chest pain or discomfort despite standard treatments. It focuses on those who cannot have or have not fully benefited from procedures like stents or bypass surgery.

Beijing, Beijing Municipality
NCT06857487Recruiting· Phase 1/Phase 2
Testing an herb formula to prevent early stroke worsening

This study tests a traditional Chinese herb formula called Qingre Huatan to see if it can stop stroke symptoms from getting worse in the first few days. It is for people who have had an ischemic stroke within the last 48 hours and are at high risk for early decline.

Beijing, Beijing Municipality
NCT07250035Recruiting· Phase 3
Chinese herb trial for brain bleed linked to amyloid angiopathy

This trial tests a traditional Chinese medicine called Jiedu Huayu to see if it helps people recover from a brain bleed caused by a condition where proteins build up in blood vessel walls (cerebral amyloid angiopathy). The goal is to improve outcomes without surgery.

Beijing
NCT06901570Not yet recruiting· Phase 4
Aromatic Wentong for heart small vessel disease

This trial tests a Chinese herbal medicine called Aromatic Wentong for people with coronary microvascular disease—a condition where the tiny blood vessels in the heart don't work properly, causing chest pain. The medicine may help improve blood flow in the small vessels.

Beijing, Chaoyang District
NCT05583773Recruiting· Phase 4
Herbal medicine for heart failure with lower pumping strength

This trial tests SHengXIaN-QuYu decoction (an herbal treatment) in people with symptomatic heart failure and reduced pumping function. It looks to see whether the herbal formula is safe and helpful for heart failure symptoms and heart function.

Beijing, Beijing Municipality
NCT06549582Not yet recruiting
Chinese medicine for stroke recovery with artery disease

This trial tests a traditional Chinese medicine prescription called 'Th Tl Xb' to see if it can help repair blood vessel damage and improve fat metabolism in people who recently had a stroke. It is for people who had their first stroke about a month ago and also have heart artery disease.

Hear when a new Acute Coronary Syndrome Comorbid With Cerebral Atherosclerosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.